Live feed08:00:00·497dPRReleaseKiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01KRBP· Kiromic BioPharma Inc.Health CareOriginal source
